These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 28852270)
1. The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer. Luo C; Zhang H Mediators Inflamm; 2017; 2017():5126048. PubMed ID: 28852270 [TBL] [Abstract][Full Text] [Related]
2. Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway. Saadatdoust Z; Pandurangan AK; Ananda Sadagopan SK; Mohd Esa N; Ismail A; Mustafa MR J Nutr Biochem; 2015 Dec; 26(12):1547-58. PubMed ID: 26355019 [TBL] [Abstract][Full Text] [Related]
3. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development. Azer SA Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309 [TBL] [Abstract][Full Text] [Related]
4. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Waldner MJ; Neurath MF Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345 [TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
7. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients. Gui X; Iacucci M; Ghosh S Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687 [TBL] [Abstract][Full Text] [Related]
9. Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model. Huo X; Liu D; Gao L; Li L; Cao L Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563884 [TBL] [Abstract][Full Text] [Related]
10. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Breynaert C; Vermeire S; Rutgeerts P; Van Assche G Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276 [TBL] [Abstract][Full Text] [Related]
11. HNE and cholesterol oxidation products in colorectal inflammation and carcinogenesis. Rossin D; Calfapietra S; Sottero B; Poli G; Biasi F Free Radic Biol Med; 2017 Oct; 111():186-195. PubMed ID: 28089726 [TBL] [Abstract][Full Text] [Related]
12. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725 [TBL] [Abstract][Full Text] [Related]
13. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Atreya R; Neurath MF Curr Drug Targets; 2008 May; 9(5):369-74. PubMed ID: 18473764 [TBL] [Abstract][Full Text] [Related]
14. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis. Brandt M; Grazioso TP; Fawal MA; Tummala KS; Torres-Ruiz R; Rodriguez-Perales S; Perna C; Djouder N Cell Metab; 2018 Jan; 27(1):118-135.e8. PubMed ID: 29275959 [TBL] [Abstract][Full Text] [Related]
16. Cytokines: from gut inflammation to colorectal cancer. Fantini MC; Pallone F Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765 [TBL] [Abstract][Full Text] [Related]
17. Loss of RNF40 Decreases NF-κB Activity in Colorectal Cancer Cells and Reduces Colitis Burden in Mice. Kosinsky RL; Chua RL; Qui M; Saul D; Mehlich D; Ströbel P; Schildhaus HU; Wegwitz F; Faubion WA; Johnsen SA J Crohns Colitis; 2019 Mar; 13(3):362-373. PubMed ID: 30321325 [TBL] [Abstract][Full Text] [Related]
18. OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment. Chen Z; Zhang X; Xing Z; Lv S; Huang L; Liu J; Ye S; Li X; Chen M; Zuo S; Tao Y; He Y Oncogene; 2022 May; 41(22):3131-3150. PubMed ID: 35487976 [TBL] [Abstract][Full Text] [Related]
19. Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis. Guo L; Ye C; Hao X; Zheng R; Ju R; Wu D; Luo L; Wang C; Li J; Yu X; Zhu L; Zhang D J Pharmacol Exp Ther; 2012 Aug; 342(2):356-65. PubMed ID: 22553216 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]